Literature DB >> 34249406

Basic approaches, challenges and opportunities for the discovery of small molecule anti-tumor drugs.

Yu-Shui Ma1,2,3, Ji-Bin Liu2, Xiao-Li Yang3, Rui Xin3, Yi Shi1,2, Dan-Dan Zhang3, Hui-Min Wang3, Pei-Yao Wang3, Qin-Lu Lin1, Wen Li1, Da Fu1,3.   

Abstract

Chemotherapy is one of the main treatments for cancer, especially for advanced cancer patients. In the past decade, significant progress has been made with the research into the molecular mechanisms of cancer cells and the precision medicine. The treatment on cancer patients has gradually changed from cytotoxic chemotherapy to precise treatment strategy. Research into anticancer drugs has also changed from killing effects on all cells to targeting drugs for target genes. Besides, researchers have developed the understanding of the abnormal physiological function, related genomics, epigenetics, and proteomics of cancer cells with cancer genome sequencing, epigenetic research, and proteomic research. These technologies and related research have accelerated the development of related cancer drugs. In this review, we summarize the research progress of anticancer drugs, the current challenges, and future opportunities. AJCR
Copyright © 2021.

Entities:  

Keywords:  Drug therapy; cancer; comprehensive utilization; inhibitor

Year:  2021        PMID: 34249406      PMCID: PMC8263657     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  129 in total

Review 1.  Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy.

Authors:  Majid Piramoon; Fatemeh Khodadust; Seyed Jalal Hosseinimehr
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-02-27       Impact factor: 10.680

2.  At the 75th anniversary of the bombings of Hiroshima and Nagasaki, the Radiation Effects Research Foundation continues studies of the atomic bomb survivors and their children.

Authors:  Jonathan M Samet; Ohtsura Niwa
Journal:  Carcinogenesis       Date:  2020-11-13       Impact factor: 4.944

3.  Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition.

Authors:  Ji Hyeon You; Jaewang Lee; Jong-Lyel Roh
Journal:  Cancer Lett       Date:  2021-03-16       Impact factor: 8.679

4.  CTGF promotes osteosarcoma angiogenesis by regulating miR-543/angiopoietin 2 signaling.

Authors:  Li-Hong Wang; Hsiao-Chi Tsai; Yu-Che Cheng; Chih-Yang Lin; Yuan-Li Huang; Chun-Hao Tsai; Guo-Hong Xu; Shih-Wei Wang; Yi-Chin Fong; Chih-Hsin Tang
Journal:  Cancer Lett       Date:  2017-01-18       Impact factor: 8.679

5.  Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.

Authors:  Fuqing Hu; Haijie Li; Lu Liu; Feng Xu; Senyan Lai; Xuelai Luo; Junbo Hu; Xi Yang
Journal:  Mol Cancer       Date:  2018-07-30       Impact factor: 27.401

6.  Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth.

Authors:  Celine Bouclier; Matthieu Simon; Guillaume Laconde; Morgan Pellerano; Sebastien Diot; Sylvie Lantuejoul; Benoit Busser; Laetitia Vanwonterghem; Julien Vollaire; Véronique Josserand; Baptiste Legrand; Jean-Luc Coll; Muriel Amblard; Amandine Hurbin; May C Morris
Journal:  Theranostics       Date:  2020-01-12       Impact factor: 11.556

7.  Study of oral microorganisms contributing to non-carious cervical lesions via bacterial interaction and pH regulation.

Authors:  Xiaoyu Huang; Lin She; Huanhuan Liu; Pingping Liu; Jue Chen; Yingcong Chen; Wenjie Zhou; Youguang Lu; Jun Lin
Journal:  J Cell Mol Med       Date:  2021-02-16       Impact factor: 5.310

8.  Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer.

Authors:  Virginia Murillo-Garzón; Irantzu Gorroño-Etxebarria; Malin Åkerfelt; Mikael Christer Puustinen; Lea Sistonen; Matthias Nees; James Carton; Jonathan Waxman; Robert M Kypta
Journal:  Nat Commun       Date:  2018-05-01       Impact factor: 14.919

9.  YAP1 Inhibition in HUVECs Is Associated with Released Exosomes and Increased Hepatocarcinoma Invasion and Metastasis.

Authors:  Yan Li; Xiaodong Zhang; Qianqian Zheng; Yijun Zhang; Yingbo Ma; Chen Zhu; Liang Yang; Xueqiang Peng; Qi Wang; Biao Wang; Xin Meng; Hangyu Li; Jingang Liu
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-21       Impact factor: 8.886

Review 10.  Syncytia Formation in Oncolytic Virotherapy.

Authors:  Chase Burton; Eric Bartee
Journal:  Mol Ther Oncolytics       Date:  2019-10-01       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.